Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Implantica AGOSTO:IMP A SDB +0.32%25 Median PS Value is kr0.00 as of Aug. 01, 2026. GuruFocus rates OSTO:IMP A SDB with a GF Score™ of 25/100. Among 335 Medical Devices & Instruments companies, Implantica AG ranks worse than 298507.16% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
As of today (2026-08-01), Implantica AG's share price is kr61.80. Implantica AG's Median PS Value is kr0.00. Therefore, Implantica AG's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for Implantica AG's Median PS Value or its related term are showing as below:
OSTO:IMP A SDB's Price-to-Median-PS-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.7 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Implantica AG (OSTO:IMP A SDB) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Implantica AG's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
61.80
/
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Implantica AG Median PS Value Related Terms
Implantica AG Median PS Value Historical Data
* Premium members only.
The historical data trend for Implantica AG's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Implantica AG Median PS Value Chart
Implantica AG Annual Data
Trend
Median PS Value
Implantica AG Semi-Annual Data
Median PS Value
OSTO:IMP A SDB vs : Median PS Value Comparison
For the Medical Devices subindustry, Implantica AG's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Implantica AG Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Implantica AG's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is .
For company reported annually, GuruFocus uses latest annual data as the TTM data. Implantica AG's Revenue per Share for the trailing twelve months (TTM) ended in . 20 was kr.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Implantica AG (OSTO:IMP A SDB) has a Median PS Value of kr0.00 as of Aug. 01, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Implantica AG and its competitors. According to the industry distribution chart, Implantica AG ranks #999999 out of 335 companies in the Medical Devices & Instruments industry.
Is Implantica AG's Median PS Value too high?
Implantica AG's current Median PS Value is kr0.00. Based on the distribution chart, Implantica AG ranks #999999 out of 335 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Implantica AG has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Implantica AG's Median PS Value compare to ?
According to the Medical Devices & Instruments industry distribution chart, Implantica AG ranks #999999 out of 335 companies for Median PS Value. This places Implantica AG in the lower half of its industry. The industry median Median PS Value is 0.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.70, based on 335 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Implantica AG and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Implantica AG's current Median PS Value is kr0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Implantica AG stock overvalued right now?
Implantica AG (OSTO:IMP A SDB) has a current Median PS Value of kr0.00. The current Median PS Value is kr0.00. Implantica AG's overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Implantica AG (OSTO:IMP A SDB), the current Median PS Value is kr0.00 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected product pipeline based partly on its two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body, and communicate with the caregiver at a distance, and a wireless energising platform designed to power remote-controlled implants wirelessly through intact skin.
25GF Score
Get the complete analysis for OSTO:IMP A SDB
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:IMP A SDB has been successfully added to your 
